Literature DB >> 32936266

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.

Francis Bessière1,2, Hugo Roccia3, Antoine Delinière1,2, Rome Charrière4, Philippe Chevalier1,2, Laurent Argaud3, Martin Cour2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32936266      PMCID： PMC7195693          DOI： 10.1001/jamacardio.2020.1787

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  6 in total

1.  Race to find COVID-19 treatments accelerates.

Authors:  Kai Kupferschmidt; Jon Cohen
Journal:  Science       Date:  2020-03-27       Impact factor: 47.728

2.  Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence.

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2020-03-23

3.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

Authors:  Barbara J Drew; Michael J Ackerman; Marjorie Funk; W Brian Gibler; Paul Kligfield; Venu Menon; George J Philippides; Dan M Roden; Wojciech Zareba
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

Review 4.  Drug-induced QT Interval Prolongation in the Intensive Care Unit.

Authors:  Cecilia Villa Etchegoyen; Guillermo Alberto Keller; Sebastian Mrad; Sixuan Cheng; Guillermo Di Girolamo
Journal:  Curr Clin Pharmacol       Date:  2017

5.  Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.

Authors:  Jinoos Yazdany; Alfred H J Kim
Journal:  Ann Intern Med       Date:  2020-03-31       Impact factor: 25.391

6.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272
  6 in total
  91 in total

1.  Day-90 survival in critically-ill patients with COVID-19 and hydroxychloroquine: a propensity analysis.

Authors:  Martin Cour; Camille Amaz; Julien Bohé; Thomas Rimmelé; Michel Ovize; Laurent Argaud
Journal:  Ann Transl Med       Date:  2021-04

2.  Measurement of the QT interval using the Apple Watch.

Authors:  Carmen Anna Maria Spaccarotella; Serena Migliarino; Annalisa Mongiardo; Jolanda Sabatino; Giuseppe Santarpia; Salvatore De Rosa; Antonio Curcio; Ciro Indolfi
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

Review 3.  Effect of Hydroxychloroquine on QTc in Patients Diagnosed with COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Angelos Arfaras-Melainis; Andreas Tzoumas; Damianos G Kokkinidis; Maria Salgado Guerrero; Dimitrios Varrias; Xiaobo Xu; Luis Cerna; Ricardo Avendano; Cameron Kemal; Leonidas Palaiodimos; Robert T Faillace
Journal:  J Cardiovasc Dev Dis       Date:  2021-05-13

Review 4.  Cardiovascular manifestations of COVID-19: An evidence-based narrative review.

Authors:  Yash Paul Sharma; Sourabh Agstam; Ashutosh Yadav; Anunay Gupta; Ankur Gupta
Journal:  Indian J Med Res       Date:  2021 Jan & Feb       Impact factor: 2.375

Review 5.  Approach to Acute Cardiovascular Complications in COVID-19 Infection.

Authors:  Lauren S Ranard; Justin A Fried; Marwah Abdalla; D Edmund Anstey; Raymond C Givens; Deepa Kumaraiah; Susheel K Kodali; Koji Takeda; Dimitrios Karmpaliotis; LeRoy E Rabbani; Gabriel Sayer; Ajay J Kirtane; Martin B Leon; Allan Schwartz; Nir Uriel; Amirali Masoumi
Journal:  Circ Heart Fail       Date:  2020-06-05       Impact factor: 8.790

6.  The impact of hydroxychloroquine-azithromycin combination on Tpeak-to-end and Tpeak-to-end/QT ratio during a short treatment course.

Authors:  Nijad Bakhshaliyev; Ramazan Özdemir
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-05-06       Impact factor: 1.468

Review 7.  Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.

Authors:  Zhihong Zuo; Ting Wu; Liangyu Pan; Chenzhe Zuo; Yingchuo Hu; Xuan Luo; Liping Jiang; Zanxian Xia; Xiaojuan Xiao; Jing Liu; Mao Ye; Meichun Deng
Journal:  Front Pharmacol       Date:  2021-02-08       Impact factor: 5.810

Review 8.  Hydroxychloroquine: A review of its safety and efficacy in COVID-19.

Authors:  Rutu H Karia; Sanjana Nagraj; Ishita Gupta; Amit Barua; Nirmaljot Kaur; Harmandeep Singh
Journal:  J Family Med Prim Care       Date:  2021-04-08

9.  Otherwise Unexplained Transient QTc Prolongation in a Patient Admitted with COVID Disease.

Authors:  Mark Coyle; Mark Wilkinson; Mark Sheehy
Journal:  Case Rep Cardiol       Date:  2021-05-31

Review 10.  Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials.

Authors:  Ahmed M Kamel; Mona S A Monem; Nour A Sharaf; Nada Magdy; Samar F Farid
Journal:  Rev Med Virol       Date:  2021-06-02       Impact factor: 11.043
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.